Fluorouracil Accord 50 mg/mL Injection

Accord Healthcare Pty Ltd

Revision date : 2018-08-28

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2018-08-28

Product name

Fluorouracil Accord 50 mg/mL Injection

Manufacturer Name

Accord Healthcare Pty Ltd

Icons in SDS

Company Information

company name

Accord Healthcare Pty Ltd

Section 2

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: Material is a clear, colourless to almost colourless solution. Harmful if swallowed. Reproductive toxicant. May cause allergic/hypersensitivity reactions. Avoid exposure during pregnancy. Avoid contact with eyes, skin and clothing. Do not taste or swallow. Wash thoroughly after handling Symptoms of Overexposure by Route of Exposure: This material is intended for Intravenous injection or, Intravenous or Intra-arterial Infusion use only. Inhalation: Inhalation of significant amounts of the product is not anticipated to occur because of the small size of individual containers. Contact with Skin or Eyes: Contact may cause mild irritation. Effects may include stinging, watering, and redness of the eyes and redness and a burning sensation on the skin. Skin contact may result in allergic skin reactions. Ingestion: Although ingestion is not an anticipated route of occupational exposure, this material is toxic if ingested. Symptoms similar to those identified under injection may occur. Injection: Local redness and pain are the primary symptoms of accidental injection in an occupational setting. Medical personnel are not anticipated to experience over-exposures to the therapeutic doses of this product. However, therapeutic effects including changes in the blood and bone marrow; internal bleeding, skin rash, skin or eye, photosensitivity, skin pigment changes, nail changes, loss of nails, tingling, pain, and swelling in the hands and feet, anaphylaxis and generalized allergic reactions, changes in blood pressure, irregular heartbeat, chest pain, and cardiac arrest, disorientation, confusion, and euphoria. See package insert for other adverse reactions associated with therapeutic doses of this product.

Potential health effects

or Risks from Exposure (An explanation in lay terms) Acute: The primary health effects anticipated in an occupational setting include mild irritation of eyes and skin as well as redness and local swelling after accidental injection. In case of over-exposure by injection, effects such as changes in the blood and bone marrow; internal bleeding, skin rash, skin or eye, photosensitivity, skin pigment changes, nail changes, loss of nails, tingling, pain, and swelling in the hands and feet, anaphylaxis and generalized allergic reactions, changes in blood pressure, irregular heartbeat, chest pain, and cardiac arrest, disorientation, confusion, and euphoria. Possible allergic reaction to material if inhaled, ingested, or in contact with skin. Cancer: No carcinogenic effects have been reported (see Section 11). Target Organs: Potential hazard to the cardiovascular, central nervous, and immune systems (see Section 11). Pre-Existing Medical Conditions: Pre-existing cardiovascular, central nervous, and immune system disorders may be aggravated by exposure to this material.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.